rs756868889
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001010892.3(RSPH4A):c.430C>T(p.Gln144*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,614,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001010892.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 11Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001010892.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RSPH4A | NM_001010892.3 | MANE Select | c.430C>T | p.Gln144* | stop_gained | Exon 1 of 6 | NP_001010892.1 | ||
| RSPH4A | NM_001161664.2 | c.430C>T | p.Gln144* | stop_gained | Exon 1 of 5 | NP_001155136.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RSPH4A | ENST00000229554.10 | TSL:1 MANE Select | c.430C>T | p.Gln144* | stop_gained | Exon 1 of 6 | ENSP00000229554.5 | ||
| RSPH4A | ENST00000368581.8 | TSL:1 | c.430C>T | p.Gln144* | stop_gained | Exon 1 of 5 | ENSP00000357570.4 | ||
| RSPH4A | ENST00000368580.4 | TSL:5 | c.430C>T | p.Gln144* | stop_gained | Exon 1 of 5 | ENSP00000357569.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251350 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74362 show subpopulations
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia 11 Pathogenic:2
The variant is observed at an extremely low frequency in the gnomAD v4.0.0 dataset (total allele frequency: 0.001%). Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with RSPH4A-related disorder (ClinVar ID: VCV000525269 /PMID: 23993197). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
Primary ciliary dyskinesia Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln144*) in the RSPH4A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RSPH4A are known to be pathogenic (PMID: 19200523). This variant is present in population databases (rs756868889, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with primary ciliary dyskinesia (PMID: 23993197, 31130284). ClinVar contains an entry for this variant (Variation ID: 525269). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at